OpenAlex
PricingAboutJobs
Log inGet started
Work

Equal access to innovative therapies and precision cancer care

HTML

Year: 2016
Type: review
Source: Nature Reviews Clinical Oncology
DOI: 10.1038/nrclinonc.2016.31
Authors: Agnès Buzyn, Jean-Yves Blay, Natalie Hoog-Labouret, Marta Jimenez, Frédérique Nowak, Marie-Cécile Le Deley, David Pérol, Christian Cailliot, Jacques Raynaud, Gilles Vassal
Institutions: Institut National du Cancer, Université de Lyon, Centre Léon Bérard, UniCancer Group, Université Paris-Sud, Inserm, Institut Gustave Roussy, Domaine Expérimental de Vassal, Fondation ARC pour la Recherche sur le Cancer
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: off-label drug use, targeted therapy, precision oncology, biomarker testing, tumor molecular profiling, advanced cancer, access to medicines, crizotinib, vemurafenib, drug safety
SDGs: Good health and well-being, Reduced inequalities

Open Access status: closed

Funders: Achievement Rewards for College Scientists Foundation, Fondation ARC pour la Recherche sur le Cancer
OpenAlex ID: W2309708317
FWCI: 1.294
Cites: 47
Cited by: 51
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms